Featured Content
Krystal Biotech has paused enrollment of its trial testing the intratumoral form of its experimental cancer drug KB707, citing a…
Krystal Biotech has paused enrollment of its trial testing the intratumoral form of its experimental cancer drug KB707, citing a…